Skip to main content

Featured

Patrick Nip visits AXA

Secretary for the Civil Service Patrick Nip today visited AXA Hong Kong & Macau to view the administering of COVID-19 vaccines.   About 360 staff and agents of the enterprise will receive either a Sinovac or BioNTech vaccine during a two-day outreach vaccination service by the Government.   Mr Nip said the Government welcomes enterprises to join hands with it in promoting the Early Vaccination for All campaign and encourages their employees to support the vaccination programme to protect the health of themselves, colleagues and clients.   He also hoped that people who get vaccinated will encourage their families and friends to do the same as a way to help build an immune barrier in Hong Kong.   He called on the public to get vaccinated as early as possible, noting that the vaccination programme is already offering more quotas for people to make bookings, and same-day tickets for vaccinations will be distributed to seniors aged 70 or above starting tomorrow.   Elderly peop

Vaccine protection under scrutiny

Secretary for Food & Health Prof Sophia Chan said experts of the Joint Scientific Committee under the Centre for Health Protection will monitor the situation of new COVID-19 variants and review the data on the protection of various vaccines against such variants.   Speaking to the media after attending a radio programme today, Prof Chan noted that the committee has given information about the protection of different vaccines against the new variants.   She said: “According to the experts, the BioNtech vaccine is able to protect against some of the variants of concern. For the Sinovac vaccine, they are still waiting for further information from Sinovac.   “The experts will continue to monitor the situation and review any data provided to the Department of Health.”   For the vaccine produced by AstraZeneca, which the Government has signed an advance purchase agreement with, Prof Chan said the Government is aware of the news reports concerning the vaccine in different countries.   “We also notice there is news from the World Health Organization and also some countries most recently said that all the adverse effects are not related to or do not have a direct relationship with the vaccination of the AstraZeneca vaccine.   “We will continue to monitor the situation and the Department of Health has asked the manufacturer for further information.”   She explained that regarding the procedure, the manufacturer must first apply for approval for use in Hong Kong and the Advisory Panel on COVID-19 Vaccines will review the data before it recommends it for authorisation by the Government.   Such a process has not yet started, Prof Chan added.
http://dlvr.it/Rw1Hth

Popular Posts